Markets:

Overview

News

Currencies

International

Treasuries

MannKind Corporation - Common Stock (NQ:MNKD)

5.915 +0.135 (+2.34%)

Streaming Delayed Price Updated: 3:54 PM EST, Feb 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MannKind Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

MannKind Announces Completion of Enrollment in U.S. Phase 4 Inhale-3 Clinical Trial in Patients Living With Type 1 Diabetes

November 06, 2023

From MannKind

Via GlobeNewswire

MannKind Corporation to Hold 2023 Third Quarter Financial Results Conference Call on November 7, 2023

October 31, 2023

From MannKind

Via GlobeNewswire

MannKind Expands Patent Portfolio With New Clofazimine Formulation Patent

October 30, 2023

From MannKind

Via GlobeNewswire

Why MannKind Stock Soared 19% Higher on Tuesday ↗

August 08, 2023

The biotech delivered quite an impressive earnings report.

Via The Motley Fool

MannKind (MNKD) Q2 2023 Earnings Call Transcript ↗

August 08, 2023

MNKD earnings call for the period ending June 30, 2023.

Via The Motley Fool

Earnings Preview For MannKind ↗

August 04, 2023

Via Benzinga

MannKind Analyst Turns Bullish, Says 'Don't Call It Comeback' ↗

October 10, 2023

Shares of MannKind Corp (NASDAQ: MNKD) were climbing in early trading on Tuesday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023 ↗

October 10, 2023

Via Benzinga

7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth ↗

September 07, 2023

Finding the best pharma stocks to buy takes a little effort, but it will pay of with these seven long-term winners.

Via InvestorPlace

Why Shares of MannKind Are Up Wednesday ↗

May 10, 2023

The company released its first-quarter earnings report on Tuesday.

Via The Motley Fool

MannKind (MNKD) Q1 2023 Earnings Call Transcript ↗

May 09, 2023

MNKD earnings call for the period ending March 31, 2023.

Via The Motley Fool

MannKind: Q1 Earnings Insights ↗

May 09, 2023

Via Benzinga

MannKind Corporation Announces Participation at Upcoming Conferences

September 05, 2023

From MannKind

Via GlobeNewswire

3 Biotech Stocks to Sell in August Before They Crash and Burn ↗

August 14, 2023

These biotech stocks are set to crash and burn, so it's probably a good idea for investors to sell in August, before it's too late.

Via InvestorPlace

Intuit To Rally More Than 20%? Here Are 10 Other Analyst Forecasts For Monday ↗

August 14, 2023

Keybanc lowered the price target for Bumble Inc. (NASDAQ: BMBL) from $25 to $24. Keybanc analyst Justin Patterson maintained an Overweight rating. Bumble shares rose 0.9% to $16.65 in pre-market...

Via Benzinga

Fox, Warner Music, Eli Lilly, Chegg And Other Big Stocks Moving Higher On Tuesday ↗

August 08, 2023

U.S. stocks traded lower, with the Dow Jones falling around 400 points on Tuesday. Here are some big stocks recording gains in today’s session. Paymentus Holdings, Inc. (NYSE: PAY) shares rose 29.4% to...

Via Benzinga

Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 08, 2023

Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser...

Via Benzinga

MannKind Corporation Reports 2023 Second Quarter Financial Results

August 07, 2023

From MannKind

Via GlobeNewswire

MannKind Corporation Announces Participation in the 2023 Wedbush PacGrow Healthcare Conference

August 01, 2023

From MannKind

Via GlobeNewswire

MannKind Corporation to Hold 2023 Second Quarter Financial Results Conference Call on August 7, 2023

July 31, 2023

From MannKind

Via GlobeNewswire

Why These 3 Stocks Are the Worst Ways to Play Biotech Right Now ↗

July 13, 2023

These three worst biotech stocks are not investable even if you're bullish on the sector overall. There are better options.

Via InvestorPlace

7 Biotech Stocks to Sell in July ↗

July 13, 2023

Running the gamut from large to small, and from commercial stage to clinical stage, these are seven top biotech stocks to sell in July.

Via InvestorPlace

MannKind Launches Inhale-3 Study to Address the Most Important Unmet Need Today in Adults Living With Type 1 Diabetes (T1D)

June 22, 2023

From MannKind

Via GlobeNewswire

7 Overvalued Penny Stocks to Sell Before June 2023 ↗

May 28, 2023

It's time to make your exit from these overvalued penny stocks to sell, as their respective valuations are unsustainable.

Via InvestorPlace

Dr. Burkhard Blank Joins MannKind as Executive Vice President of Research & Development and Chief Medical Officer

May 24, 2023

From MannKind

Via GlobeNewswire

3 Biotech Stocks to Avoid Like the Plague ↗

May 23, 2023

Investors are looking for bargains in the biotech sector. But these three biotech stocks should be avoided at all costs.

Via InvestorPlace

Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

May 10, 2023

Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday.

Via Benzinga

Upstart, Compass, RingCentral And Other Big Stocks Moving Higher On Wednesday ↗

May 10, 2023

U.S. stocks traded mixed, with the Dow Jones dropping around 70 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

MannKind Corporation to Participate in the 2023 RBC Capital Markets Global Healthcare Conference

May 10, 2023

From MannKind

Via GlobeNewswire

CORRECTION -- MannKind Corporation Reports 2023 First Quarter Financial Results

May 09, 2023

Conference Call to Begin Today at 5:00 p.m. (ET)

From MannKind

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

MannKind Corporation - Common Stock (NQ:MNKD)

All News about MannKind Corporation - Common Stock

Starting at $3.75/week.

Subscribe Today